Time to Benefit of Surgery vs Targeted Medical Therapy for Patients With Primary Aldosteronism: A Meta-analysis
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Context: Primary aldosteronism (PA) is one of the most common causes of secondary hypertension, but the comparative outcomes of targeted treatment remain unclear. Objective: To compare the clinical outcomes in patients treated for primary aldosteronism over time. Methods: Medline and EMBASE were searched. Original studies reporting the incidence of mortality, major adverse cardiovascular outcomes (MACE), progression to chronic kidney disease, or diabetes following adrenalectomy vs medical therapy were selected. Two reviewers independently abstracted data and assessed study quality. Standard meta-analyses were conducted using random-effects models to estimate relative differences. Time to benefit meta-analyses were conducted by fitting Weibull survival curves to estimate absolute risk differences and pooled using random-effects models. Results: 15 541 patients (16 studies) with PA were included. Surgery was consistently associated with an overall lower risk of death (hazard ratio [HR] 0.34, 95% CI 0.22-0.54) and MACE (HR 0.55, 95% CI 0.36-0.84) compared with medical therapy. Surgery was associated with a significantly lower risk of hospitalization for heart failure (HR 0.48 95% CI 0.34-0.70) and progression to chronic kidney disease (HR 0.62 95% CI 0.39-0.98), and nonsignificant reductions in myocardial infarction and stroke. In absolute terms, 200 patients would need to be treated with surgery instead of medical therapy to prevent 1 death after 12.3 (95% CI 3.1-48.7) months. Conclusion: Surgery is associated with lower all-cause mortality and MACE than medical therapy for PA. For most patients, the long-term surgical benefits outweigh the short-term perioperative risks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, given the known variability in dual human data extraction accuracy (reported rates: 65.8-85.5%) 14-19 , original author-extracted values were not treated as a definitive gold standard”
From Automation of Systematic Reviews with Large Language Models (2025) · cites this paper as [16]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“For human data extraction, we determined sample size using a McNemar test for sample size approximation. Using an estimated human accuracy of 80% (reported rates: 65.8-85.5%) 14-19 , LLM accuracy of 90%, and 95% confidence, we determined a minimum number of 204 variables per study to be extracted.”
From Automation of Systematic Reviews with Large Language Models (2025) · cites this paper as [16]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Prior research has shown wide variability in the accuracy of dual human extraction, with reported rates ranging from 65.8-85.5% 14-19 .”
From Automation of Systematic Reviews with Large Language Models (2025) · cites this paper as [16]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Sensitivity analysis in observational research: Introducing the E-value
VanderWeele, T. J., & Ding, P. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2607 · Cited by 6,350
Practical methods for incorporating summary time-to-event data into meta-analysis.
Tierney, J. F., Stewart, L. A., Ghersi, D., Burdett, S., & Sydes, M. R. (2007) · Trials · doi:10.1186/1745-6215-8-16 · Cited by 6,208
Funder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young, W. F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4061 · Cited by 2,925
Guyot, P., Ades, A., Ouwens, M. J., & Welton, N. J. (2012) · BMC Medical Research Methodology · doi:10.1186/1471-2288-12-9 · Cited by 2,526
Peters, J. L., Sutton, A. J., Jones, D. R., Abrams, K. R., & Rushton, L. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.11.010 · Cited by 2,053
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X., Plouin, P.-F., Blacher, J., Safar, M. E., & Mourad, J.-J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,547
Monticone, S., D'Ascenzo, F., Moretti, C., Williams, T. A., Veglio, F., Gaita, F., & Mulatero, P. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30319-4 · Cited by 1,072
Hundemer, G. L., Curhan, G. C., Yozamp, N., Wang, M., & Vaidya, A. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30367-4 · Cited by 677
Self-citationThe Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study
Brown, J. M., Siddiqui, M., Calhoun, D. A., Carey, R. M., Hopkins, P. N., Williams, G. H., & Vaidya, A. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0065 · Cited by 649
Cardiovascular Outcomes in Patients With Primary Aldosteronism After Treatment
Catena, C. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.33 · Cited by 565
Nishikawa, T., Omura, M., Satoh, F., Shibata, H., Takahashi, K., Tamura, N., & Tanabe, A. (2011) · Endocrine Journal · doi:10.1507/endocrj.ej11-0133 · Cited by 534
Savard, S., Amar, L., Plouin, P.-F., & Steichen, O. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01060 · Cited by 505
Long-Term Cardio- and Cerebrovascular Events in Patients With Primary Aldosteronism
Mulatero, P., Monticone, S., Bertello, C., Viola, A., Tizzani, D., Iannaccone, A., Crudo, V., Burrello, J., Milan, A., Rabbia, F., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2805 · Cited by 415
Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension
Freeman, M. W., Halvorsen, Y.-D., Marshall, W., Pater, M., Isaacsohn, J., Pearce, C., Murphy, B., Alp, N., Srivastava, A., Bhatt, D. L., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2213169 · Cited by 395
Catena, C., Colussi, G., Lapenna, R., Nadalini, E., Chiuch, A., Gianfagna, P., & Sechi, L. A. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.095448 · Cited by 358
Reconstructing Time-to-event Data from Published Kaplan–Meier Curves
Wei, Y., & Royston, P. (2017) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x1801700402 · Cited by 282
Parthasarathy, H. K., Ménard, J., White, W. B., Young, W. F., Williams, G. H., Williams, B., Ruilope, L. M., McInnes, G. T., Connell, J. M., & MacDonald, T. M. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283455ca5 · Cited by 281
Observational Study Mortality in Treated Primary Aldosteronism: The German Conn's Registry
Reincke, M., Fischer, E., Gerum, S., Merkle, K., Schulz, S., Pallauf, A., Quinkler, M., Hanslik, G., Lang, K., Hahner, S., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.197111 · Cited by 278
American Association of Endocrine Surgeons Guidelines for Adrenalectomy: Executive Summary
Yip, L., Duh, Q.-Y., Wachtel, H., Jimenez, C., Sturgeon, C., Lee, C., Velázquez-Fernández, D., Berber, E., Hammer, G. D., Bancos, I., et al. (2022) · JAMA Surgery · doi:10.1001/jamasurg.2022.3544 · Cited by 258
Aldosterone, Inflammation, Immune System, and Hypertension
Ferreira, N. S., Tostes, R. C., Paradis, P., & Schiffrin, E. L. (2021) · American Journal of Hypertension · doi:10.1093/ajh/hpaa137 · Cited by 248
Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism
Hundemer, G. L., Curhan, G. C., Yozamp, N., Wang, M., & Vaidya, A. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11568 · Cited by 245
Self-citationHundemer, G. L., Curhan, G. C., Yozamp, N., Wang, M., & Vaidya, A. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.2003 · Cited by 240
Self-citationAldosterone as a Mediator of Cardiovascular Damage
Buffolo, F., Tetti, M., Mulatero, P., & Monticone, S. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.17964 · Cited by 228
Lee, S. J., Boscardin, W. J., Stijacic-Cenzer, I., Conell-Price, J., O'Brien, S., & Walter, L. C. (2012) · BMJ · doi:10.1136/bmj.e8441 · Cited by 225
Self-citationIncorporating Lag Time to Benefit Into Prevention Decisions for Older Adults
Lee, S. J., Leipzig, R. M., & Walter, L. C. (2013) · JAMA · doi:10.1001/jama.2013.282612 · Cited by 203
Self-citationAdrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term
Rossi, G. P., Maiolino, G., Flego, A., Belfiore, A., Bernini, G., Fabris, B., Ferri, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10596 · Cited by 194
Risk Factors Associated with a Low Glomerular Filtration Rate in Primary Aldosteronism
Reincke, M., Rump, L. C., Quinkler, M., Hahner, S., Diederich, S., Lorenz, R., Seufert, J., Schirpenbach, C., Beuschlein, F., Bidlingmaier, M., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1851 · Cited by 175
Albasri, A., Hattle, M., Koshiaris, C., Dunnigan, A., Paxton, B., Fox, S. E., Smith, M., Archer, L., Levis, B., Payne, R. A., et al. (2021) · BMJ · doi:10.1136/bmj.n189 · Cited by 163
Long term outcome of Aldosteronism after target treatments
Wu, V.-C., Wang, S.-M., Chang, C.-H., Hu, Y.-H., Lin, L.-Y., Lin, Y.-H., Chueh, S.-C. J., Chen, L., & Wu, K.-D. (2016) · Scientific Reports · doi:10.1038/srep32103 · Cited by 148
Wu, X., Senanayake, R., Goodchild, E., Bashari, W. A., Salsbury, J., Cabrera, C. P., Argentesi, G., O’Toole, S. M., Matson, M., Koo, B., et al. (2023) · Nature Medicine · doi:10.1038/s41591-022-02114-5 · Cited by 148
Deardorff, W. J., Cenzer, I. S., Nguyen, B., & Lee, S. J. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2021.6745 · Cited by 146
Self-citationSystematic review of surgery and outcomes in patients with primary aldosteronism
Muth, A., Ragnarsson, Ó., Johannsson, G., & Wängberg, B. (2015) · British journal of surgery · doi:10.1002/bjs.9744 · Cited by 138
Reconstructing time-to-event data from published Kaplan–Meier curves
Wei, Y., & Royston, P. J. (2017) · PubMed · doi:10.22004/ag.econ.340230 · Cited by 138
Yourman, L. C., Cenzer, I. S., Boscardin, W. J., Nguyen, B. T., Smith, A. K., Schonberg, M. A., Schoenborn, N. L., Widera, E. W., Orkaby, A., Rodriguez, A., et al. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.6084 · Cited by 133
Self-citationIwakura, Y., Morimoto, R., Kudo, M., Ono, Y., Takase, K., Seiji, K., Arai, Y., Nakamura, Y., Sasano, H., Ito, S., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2180 · Cited by 126
Chen, Y., Scholten, A., Chomsky‐Higgins, K. H., Nwaogu, I. Y., Gosnell, J. E., Seib, C. D., Shen, W. T., Suh, I., & Duh, Q. (2018) · JAMA Surgery · doi:10.1001/jamasurg.2018.2648 · Cited by 118
Outcomes of Adrenalectomy in Patients with Unilateral Primary Aldosteronism: A Review
Steichen, O., Zinzindohoué, F., Plouin, P., & Amar, L. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0031-1299681 · Cited by 117
The "number needed to treat" turns 20 -- and continues to be used and misused
McAlister, F. A. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.080484 · Cited by 108
The Impact of Nocturia on Mortality: A Systematic Review and Meta-Analysis
Pesonen, J. S., Cartwright, R., Vernooij, R. W. M., Aoki, Y., Agarwal, A., Mangera, A., Markland, A. D., Tsui, J. F., Santti, H., Griebling, T. L., et al. (2019) · The Journal of Urology · doi:10.1097/ju.0000000000000463 · Cited by 101
Vukadinović, D., Lavall, D., Vukadinović, A. N., Pitt, B., Wagenpfeil, S., & Böhm, M. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.03.011 · Cited by 94
Methods to Address Confounding and Other Biases in Meta-Analyses: Review and Recommendations
Mathur, M. B., & VanderWeele, T. J. (2022) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-051920-114020 · Cited by 85
Sever, P., Poulter, N. R., Dahlöf, B., & Wedel, H. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.06.025 · Cited by 81
Chen, S.-Y., Chen, J., Huang, W., Puar, T. H. K., Kek, P. C., Chueh, S., Lin, Y., Wu, V., & TAIPAI Study Group (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0375 · Cited by 78
Wu, V.-C., Wang, S.-M., Huang, K.-H., Tsai, Y. C., Chan, C.-K., Yang, S.-Y., Lin, L.-Y., Chang, C., Lu, C.-C., Lin, Y.-H., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0836 · Cited by 71
Mineralocorticoid Antagonists Treatment Versus Surgery in Primary Aldosteronism
Catena, C., Colussi, G., Fabio, A. D., Valeri, M., Marzano, L. A., Uzzau, A., & Sechi, L. A. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0029-1246185 · Cited by 62
Satoh, M., Maruhashi, T., Yoshida, Y., & Shibata, H. (2019) · Hypertension Research · doi:10.1038/s41440-019-0244-4 · Cited by 51
Kline, G. A., Pasieka, J. L., Harvey, A. M., So, B., & Dias, V. C. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-2871-3 · Cited by 50
Self-citationTang, V., Boscardin, W. J., Stijacic-Cenzer, I., & Lee, S. J. (2015) · BMJ · doi:10.1136/bmj.h1662 · Cited by 49
Self-citationChen, Y., Lin, Y.-H., Huang, W., Chueh, E., Chen, L., Yang, S., Lin, P., Lin, L., Lin, Y., Wu, V., et al. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00019 · Cited by 49
Cardiovascular changes in patients with primary aldosteronism after surgical or medical treatment.
BERNINI, G. P., Bacca, A., Carli, V., Carrara, D., Materazzi, G., Berti, P., Miccoli, P., Pisano, R., Tantardini, V., Bernini, M., et al. (2012) · PubMed · doi:10.3275/7611 · Cited by 42
Ambrosino, P., Lupoli, R., Tortora, A., Cacciapuoti, M., Lupoli, G., Tarantino, P., Nasto, A., & Minno, M. N. D. D. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.01.200 · Cited by 42
Estimating the relative hazard by the ratio of logarithms of event-free proportions
Perneger, T. (2008) · Contemporary Clinical Trials · doi:10.1016/j.cct.2008.06.002 · Cited by 39
Outcomes in unilateral primary aldosteronism after surgical or medical therapy
Puar, T. H. K., Loh, L. M., Loh, W. J., Lim, D. S. T., Zhang, M., Tan, P. T., Lee, L. M. Y., Swee, D. S., Khoo, J. J. C., Tay, D., et al. (2020) · Clinical Endocrinology · doi:10.1111/cen.14351 · Cited by 33
Surgery decreases the long-term incident stroke risk in patients with primary aldosteronism
Chang, Y.-H., Chung, S., Wu, C., Chueh, S., Chen, L., Lin, P., Lin, Y., Huang, K., Wu, V., & Chu, T. (2019) · Surgery · doi:10.1016/j.surg.2019.08.017 · Cited by 31
Kim, K. J., Hong, N., Yu, M. H., Lee, H., Lee, S., Lim, J. S., & Rhee, Y. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16909 · Cited by 31
Self-citationCastro, M. A., Paja, M., Boillos, M. G., Peris, B. P., Corrales, E. P., Cano, A. M. G., Ramírez, P. A. P., Rojas‐Marcos, P. M., Ruiz-Sánchez, J. G., Delgado, A. V., et al. (2022) · Endocrine · doi:10.1007/s12020-022-03029-4 · Cited by 30
Huang, W., Chen, Y., Lin, Y., & Chueh, S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.644260 · Cited by 29
Outcomes analysis of surgical and medical treatments for patients with primary aldosteronism
Park, K. S., Kim, J. H., Yang, Y., Hong, A. R., Lee, D., Moon, M. K., Choi, S. H., Shin, C. S., Kim, S. W., & Kim, S. Y. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej16-0530 · Cited by 27
E-values for effect heterogeneity and approximations for causal interaction
Mathur, M. B., Smith, L. H., Yoshida, K., Ding, P., & VanderWeele, T. J. (2022) · International Journal of Epidemiology · doi:10.1093/ije/dyac073 · Cited by 25
SFE/SFHTA/AFCE consensus on primary aldosteronism, part 6: Adrenal surgery
Steichen, O., Amar, L., Chaffanjon, P. C., Kraimps, J., Ménégaux, F., & Zinzindohoué, F. (2016) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.01.009 · Cited by 24
Outcomes of Drug-Based and Surgical Treatments for Primary Aldosteronism
Steichen, O., Lorthioir, A., Zinzindohoué, F., Plouin, P., & Amar, L. (2015) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.10.003 · Cited by 21
An Individualized Approach to The Evaluation and Management of Primary Aldosteronism
Vaidya, A., Malchoff, C. D., & Auchus, R. J. (2017) · Endocrine Practice · doi:10.4158/ep161717.ra · Cited by 21
External Validation of Clinical Prediction Models in Unilateral Primary Aldosteronism
Sam, D., Kline, G. A., So, B., Hundemer, G. L., Pasieka, J. L., Harvey, A. M., Chin, A., Przybojewski, S. J., Caughlin, C. E., & Leung, A. A. C. (2021) · American Journal of Hypertension · doi:10.1093/ajh/hpab195 · Cited by 20
Self-citationTime to benefit for stroke reduction after blood pressure treatment in older adults: A meta‐analysis
Ho, V. S., Cenzer, I. S., Nguyen, B. T., & Lee, S. J. (2022) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17684 · Cited by 20
Self-citationNakamaru, R., Yamamoto, K. I., Akasaka, H., Rakugi, H., Kurihara, I., Yoneda, T., Ichijo, T., Katabami, T., Tsuiki, M., Wada, N., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-86290-3 · Cited by 13
Turrentine, F. E., Stukenborg, G. J., Hanks, J. B., & Smith, P. W. (2015) · The American Surgeon · doi:10.1177/000313481508100534 · Cited by 12
Leung, A. (2023) · Borealis · doi:10.5683/sp3/bfjcqh
Self-citation
Cited by
Writing Committee Members*, Jones, D. W., Ferdinand, K. C., Taler, S. J., Johnson, H. M., Shimbo, D., Abdalla, M., Altieri, M. M., Bansal, N., Bello, N. A., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001356 · Cited by 213
Writing Committee Members*, Jones, D. W., Ferdinand, K. C., Taler, S. J., Johnson, H. M., Shimbo, D., Abdalla, M., Altieri, M. M., Bansal, N., Bello, N. A., et al. (2025) · Hypertension · doi:10.1161/hyp.0000000000000249 · Cited by 310
Jones, D. W., Ferdinand, K. C., Taler, S. J., Johnson, H. M., Shimbo, D., Abdalla, M., Altieri, M. M., Bansal, N., Bello, N. A., Bress, A. P., et al. (2025) · JACC · doi:10.1016/j.jacc.2025.05.007 · Cited by 280
Ohya, Y., Arakawa, K., Arata, N., Arima, S., Arima, H., Asayama, K., Dohi, Y., Fukami, A., Furuhashi, M., Goto, K., et al. (2026) · Hypertension Research · doi:10.1038/s41440-025-02462-y · Cited by 107
Development of Prompt Templates for Large Language Model–Driven Screening in Systematic Reviews
Cao, C., Sang, J., Arora, R., Chen, D., Kloosterman, R., Cecere, M., Gorla, J., Saleh, R., Drennan, I., Teja, B., et al. (2025) · Annals of Internal Medicine · doi:10.7326/annals-24-02189 · Cited by 91
Self-citation
Metadata
- Authors
- Samnani, S., Cenzer, I., Kline, G. A., Lee, S. J., Hundemer, G. L., McClurg, C., Pasieka, J. L., Boscardin, W. J., Ronksley, P. E., & Leung, A. A.
- Affiliations
- University of Calgary (CA)
- San Francisco VA Medical Center (US)
- University of Ottawa (CA)
- University of California, San Francisco (US)
- Corresponding author
- Leung, Alexander A
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2023-11-08
- Volume
- 109
- Issue
- 3
- Pages
- e1280-e1289
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC10876395
- OpenAlex
- W4388578725
- Cited by
- 50
- References
- 70
- Citations by year
- 2026: 15 · 2025: 23 · 2024: 11 · 2023: 1
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (PJT-159533)
- Heart and Stroke Foundation of Canada’s National New Investigator Award
- Lorna Jocelyn Wood Chair in Kidney Research
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- primary aldosteronism, adrenalectomy, medical therapy, all-cause mortality, major adverse cardiovascular events, heart failure hospitalization, chronic kidney disease progression, diabetes mellitus, secondary hypertension, perioperative risk
- MeSH terms
- Diabetes Mellitus, Humans, Hyperaldosteronism, Hypertension, Time, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.